deltatrials
Completed NA INTERVENTIONAL 1-arm NCT04645615

European CURE-AF Study

European CURE-AF Study - Concomitant Utilization of Radiofrequency Energy for Atrial Fibrillation

Sponsor: Medtronic Cardiovascular

Conditions Atrial Fibrillation
Interventions Cardioblate surgical ablation system Surgical RF Ablation
Updated 4 times since 2020 Last updated: Nov 20, 2020 Started: Jun 19, 2008 Primary completion: Feb 28, 2011 Completion: Jul 10, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Atrial Fibrillation, this trial is completed. The trial is conducted by Medtronic Cardiovascular and has accumulated 4 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Dec 2020 — Jan 2021 [monthly]

    Completed NA

    First recorded

Jun 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Medtronic Cardiovascular
Data source: Medtronic Cardiovascular

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations